Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003851 · ClinicalTrials.gov registry record · NA
Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer
A NA study, sponsored by Columbia University.
- Terminated
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT00003851 is a NA study that was terminated before completion, run by Columbia University. The registered enrollment target is 90 participants.
The verdict
NCT00003851, a NA study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Pancreatic enzymes may help kill cancer cells. It is not yet known if gemcitabine is more effective than pancreatic enzyme therapy plus specialized diet for pancreatic cancer. PURPOSE: This clinical trial is comparing the effectiveness of gemcitabine with that of pancreatic enzyme therapy plus specialized diet (Gonzalez regimen) in treating patients who have stage II, stage III, or stage IV pancreatic cancer.
Interventions
- DRUG gemcitabine hydrochloride
- BIOLOGICAL proteolytic enzymes
- PROCEDURE Gonzalez regimen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 1999-03 |
| Est. Completion | 2004-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003851
The ClinicalTrials.gov registry entry for NCT00003851 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which gemcitabine hydrochloride is the first listed.
NCT00003851 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003851 about?
NCT00003851 is a clinical study titled "Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Pancreatic enzymes may help kill cancer cells. It is not yet known if gemcitabine is more effective than pancreatic enzyme therapy plus specialized diet for pancreatic cancer. PUR...
What is the current status of trial NCT00003851?
This trial is currently terminated. It is a NA study. The enrollment target is 90 participants. The study started on 1999-03. Estimated completion is 2004-07.
What interventions are being tested in trial NCT00003851?
The interventions under investigation include: gemcitabine hydrochloride (DRUG), proteolytic enzymes (BIOLOGICAL), Gonzalez regimen (PROCEDURE).
Who is sponsoring clinical trial NCT00003851?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.